HMGB1 and colitis: Ethyl pyruvate, a redox analog of DMF, exerted similarly beneficial effects in a murine model of colitis, leading to the improvement of symptoms and a decrease in high mobility group box 1 (HMGB1), a key mediator of inflammation [64].